Amalgamated Financial’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Amalgamated Financial’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$12K	Buy	+2,368	New	+$19K	﹤0.01%	2870

Other funds holding RAIN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's RAIN Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Rain Oncology Inc. Common Stock (RAIN) in Q1 2022: 2,368 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #2870 among its holdings.

49 funds tracked by Wall St. Rank hold RAIN as of Q1 2022.

Amalgamated Financial held 2,368 shares of Rain Oncology Inc. Common Stock worth $12K as of Q1 2022.
Rain Oncology Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Rain Oncology Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2870 holding.
49 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.